Clinical Trial

Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this multicenter randomized clinical trial is to evaluate the myopia control effect of orthokeratology and 0.01% atropine sequential treatment in children and adolescents, as compared to continuous treatment with orthokeratology.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-29.
Status change: Not Yet Recruiting → Recruiting 2025-02-25
Trial Details
NCT Number NCT06667037
Lead Sponsor Zhongshan Ophthalmic Center, Sun Yat-sen University
Collaborators: People's Hospital of Guangxi, Henan Provincial People's Hospital, Tianjin Medical University Eye Hospital
Conditions Myopia
Enrollment 194 participants
Start Date 2024-09-21
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-26